Johnson and Johnson Merck Consumer Pharmaceuticals

Bookmark

Add to MyYahoo RSS

Johnson and Johnson Merck Consumer Pharmaceuticals News

News on Johnson and Johnson Merck Consumer Pharmaceuticals continually updated from thousands of sources around the net.

14 hrs ago | Bioscience Technology

Vivus acquires patent rights to Qsymia ingredient

Vivus has acquired a group of patents covering one of the main ingredients behind its weight loss drug Qsymia from Janssen Pharmaceuticals.

Comment?

Related Topix: Startups, VIVUS, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Scios

18 hrs ago | WebWire

ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.

ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Mon Aug 25, 2014

GuruFocus.com

Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs

Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Sys-Con Media

Janssen Affiliate Cilag GmbH International Acquires Covagen AG

The opportunity was identified and facilitated through the Johnson & Johnson Innovation Center in .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Sat Aug 23, 2014

The San Diego Union-Tribune

Viacyte Partners with Janssen on Diabetes Therapy

San Diego's ViaCyte has received $20 million from a drug company to advance its stem cell-based therapy for Type 1 diabetes into human clinical trials.

Comment?

Related Topix: Medicine, Diabetes, Health, Stem Cell Research, Science / Technology, Johnson & Johnson, Biotech, Johnson and Johnson, Healthcare Industry

PR-inside.com

New market study, "McNeil Iberica SLU in Consumer Health (Spain)", has been published

However, during 2013 the company showed a much lower profile in terms of new launches and television campaigns.

Comment?

Related Topix: Euromonitor International, Advertising, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Nutrition

Fri Aug 22, 2014

TheStreet.com

Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf

In 2010, emerging markets spent more than Germany, France, Italy, Spain and the U.K. combined.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Facet Biotech, Abbott Labs, Absolute Software, Software

Bizcommunity

SMS service for pregnant women

A new cellphone application, MomConnect, allows all pregnant women in the country to sign up for a free SMS service, which provides information and advice on pregnancy, and can be used to notify the Department of Health about poor services at clinics.

Comment?

Related Topix: Cellphones, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

Thu Aug 21, 2014

BioSpace

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Signing Of Rights Agreement With

The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01 combination product that ViaCyte is developing for type 1 diabetes.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Forbes.com

Dow Movers: BA, JNJ

Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

MarketWatch

Jeff Reeves's Strength in Numbers: This one stock sector can withstand all the 'bubble' talk

A beleaguered Johnson & Johnson has rebounded since January 2013, with its stock jumping 50% to beat the S&P 500.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Financial Markets, Wellpoint Health Networks, Insurance

Forbes.com

Illumina Partners With Big PharmaTo Create New Genetic Tests For Cancer

I believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today.

Comment?

Related Topix: Genetics, Medicine, Johnson & Johnson, Biotech, Johnson and Johnson, Healthcare Industry, Food and Drug Administration

Tue Aug 19, 2014

Insider Monkey

Apple Inc. (AAPL), American Express Company (AXP), Johnson & Johnson...

Ken Fisher 's Fisher Asset Management filed a few weeks ago its Form 13F for the second quarter of 2014.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Apple, VisionCare Ophthalmic Technologies, Startups, Financial Services, Travelers Express Company

The Motley Fool

3 Reasons Hospira, Inc. Stock Could Rise

Last quarter, the maker of specialty injectable pharmaceuticals and medical devices reported that its revenue rose 11% year-over-year to $1.1 billion, while its adjusted earnings per share rose 31% to $0.72 per share.

Comment?

Related Topix: Hispanic Broadcasting, Television, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Mon Aug 18, 2014

Seeking Alpha

2 U.S. IPOs Planned For The Week Of August 18

Only two IPOs are expected to begin trading this week, both holdovers from last week that had originally been on the calendar for the week of August 4. The IPO market has begun its annual late-August hiatus, as last week's two deals trade just 1% from the IPO price and none are expected for next week.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Minneapolis, MN

Pharmaceutical Executive

TTIP: From Hot Tip to Oblivion?

Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Insider Monkey

Apple Inc. (AAPL), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Among...

AQR Capital Management , managed by Cliff Asness , recently published its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Apple, Startups, Pfizer, Conor Medsystems

Product Defect News

Have You Been Injured By A Defective Hip Implant?

When your car is a lemon or is recalled for safety issues, you get it fixed at no cost at the dealership.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Forbes.com

Interesting April 2015 Stock Options for Johnson & Johnson

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Bizcommunity

The NOW Project 2014 update - a future proofing segmentation tool

The NOW Project is a unique segmentation that delivers insights into the hearts and minds of the people of RSA, enabling marketers to read change and position brands with a future facing perspective.

Comment?

Related Topix: World News, South Africa, Africa, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Aria Systems

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••